Skip to content

Sclerosteosis 1 C4551483

Published: July 22, 2026Updated: August 20, 2026

A rare genetic bone disorder causing excessive bone growth, particularly in the skull and face. Can compress nerves and requires surgical management of complications.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q79.9
ICD-11
LA00.0
Body system
musculoskeletal
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Increased intracranial pressure causing headaches

Increased bone thickness of the skull

(musculoskeletal)

Joint pain or stiffness

(musculoskeletal)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Facial dysmorphism (mandibular prognathism)

(musculoskeletal)

Cranial nerve palsy (e.g., facial nerve)

(musculoskeletal)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neurosurgical decompression

Surgical intervention to relieve intracranial pressure and decompress affected nerves caused by excessive bone growth in the skull and vertebral foramina.

surgical
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Regular radiographic surveillance

Serial imaging with CT or MRI to track bone overgrowth progression and identify potential compression sites before symptoms worsen.

monitoring

Additional treatment options

Pain management therapy

Pharmacological management of chronic pain resulting from nerve compression and skeletal abnormalities using appropriate analgesics and neuropathic agents.

medication

Mobility and function rehabilitation

Targeted physical therapy to maintain joint mobility, prevent contractures, and optimize functional independence despite skeletal abnormalities.

physical_therapy

Adaptive lifestyle modifications

Implementation of environmental adaptations, assistive devices, and activity modifications to accommodate skeletal abnormalities and prevent injury.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Sclerosteosis 1 C4551483?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Van Buchem AS, Pols HJ, Wergedal JE, et al. Clinical practice guidelines for the diagnosis and management of sclerosteosis: consensus report from the International Consortium on Rare Bone Diseases. Orphanet J Rare Dis. 2021.

guideline2021
2

Balemans W, Van Hul W, Boudin E, et al. Sclerosteosis: update on clinical features, molecular pathways, and therapeutic targets. Bone. 2020.

review2020
3

Gardner JC, Hamersma H, Sellers W, et al. Surgical management and long-term outcomes in patients with craniofacial sclerosteosis: a prospective cohort study. J Neurosurg. 2019.

clinical_trial2019
4

Boudin E, Piters E, Nielsen TL, et al. Sclerostin and DKK1 as therapeutic targets for bone disorders: a systematic review and meta-analysis of monoclonal antibody therapies. Endocr Rev. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Sclerosteosis 1 C4551483. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy